Patent ID: 11900592
Assignee: PING AN TECHNOLOGY (SHENZHEN) CO., LTD
Field: Medical technology (Instruments)
Classification: CPC G  A | IPC A  G

Claim 1:
2. The method according to claim 1, further comprising:
providing a treatment recommendation, based on a degree of malignancy of the segmented pancreatic mass;
wherein:
the type of the segmented pancreatic mass includes pancreatic ductal adenocarcinoma (PDAC), ampullary cancer (AC), bile duct cancer (DC), pancreatic neuroendocrine tumor (PNET), rare neo-plasma (RARE), solid pseudopapillary tumor (SPT), chronic pancreatitis (CP), intraductal papillary mucinous neoplasm (IPMN), mucinous cystic neoplasm (MCN), and serous cystic neoplasm (SCN);
the grade of the segmented pancreatic mass includes a low grade, an intermediate grade, and a high grade;
PDAC, AC, DC, PNET, RARE, and SPT are malignant types, CP, IPMN, and MCN are potentially malignant types, and SCN is a non-malignant type; and
the patient with the malignant types and the potentially malignant types with the high grade need immediate treatment, the patient with the potentially malignant types with the low and intermediate grades need monitoring, and the patient with the non-malignant type is discharged.